Skip to content
★ Sign in to follow
SW
Total declarations
22
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (14 ops.)
€2.2M

Latest filing published 03 Aug 2017 for Evolent Health, Inc., €20k.

Filing timeline

BuySale
Steve Wigginton

Insider track record

Disclosed buys
0
Disclosed sells
14
Signal history

Steve Wigginton: trading record in brief

Steve Wigginton discloses dealings in Evolent Health, Inc. to SEC (Form 4). We count 22 filings; the first trade dates from 1 March 2016 and the latest from 1 August 2017.

Every open-market trade on record is a sale: 14 sales worth €2.2M. Besides market trades, the filings include 1 share grant and 7 option exercises. In 2017 alone, the filings show no purchases and 13 sales.

The newest entry dates from 3 August 2017: an option exercise of €20k, in Evolent Health, Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Steve Wigginton

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations22 total
  • ◇
    CEO, Valence HealthExecutivesEvolent Health, Inc.
    23,040 USD22SEC
    6,000 shares@ US$3.840.8% of flowClass A Common StockSEC:0001628908-17-000038:0
  • ▼
    CEO, Valence HealthExecutivesEvolent Health, Inc.
    147,840 USD41SEC
    6,000 shares@ US$24.645.3% of flowClass A Common StockSEC:0001628908-17-000038:1
  • ◇
    CEO, Valence HealthExecutivesEvolent Health, Inc.
    23,040 USD22SEC
    6,000 shares@ US$3.840.9% of flowClass A Common StockSEC:0001628908-17-000034:0
  • ▼
    CEO, Valence HealthExecutivesEvolent Health, Inc.
    150,420 USD41SEC
    6,000 shares@ US$25.075.6% of flowClass A Common StockSEC:0001628908-17-000034:1
  • ▼
    CEO, Valence HealthExecutivesEvolent Health, Inc.
    24,694 USD40SEC
    959 shares@ US$25.750.9% of flowClass A Common StockSEC:0001232583-17-000007:0
  • ◇
    CEO, Valence HealthExecutivesEvolent Health, Inc.
    23,040 USD22SEC
    6,000 shares@ US$3.840.9% of flowClass A Common StockSEC:0001232583-17-000006:0
  • ▼
    CEO, Valence HealthExecutivesEvolent Health, Inc.
    37,616 USD40SEC
    1,600 shares@ US$23.511.4% of flowClass A Common StockSEC:0001232583-17-000006:1
  • ▼
    CEO, Valence HealthExecutivesEvolent Health, Inc.
    107,184 USD40SEC
    4,400 shares@ US$24.364.0% of flowClass A Common StockSEC:0001232583-17-000006:2
  • ▼
    CEO, Valence HealthExecutivesEvolent Health, Inc.
    331,452 USD41SEC
    13,640 shares@ US$24.3012.6% of flowClass A Common StockSEC:0000950157-17-000723:0
  • ◇
    CEO, Valence HealthExecutivesEvolent Health, Inc.
    23,040 USD22SEC
    6,000 shares@ US$3.840.9% of flowClass A Common StockSEC:0001232583-17-000005:0
  • ▼
    CEO, Valence HealthExecutivesEvolent Health, Inc.
    138,600 USD41SEC
    6,000 shares@ US$23.105.4% of flowClass A Common StockSEC:0001232583-17-000005:1
  • ◇
    CEO, Valence HealthExecutivesEvolent Health, Inc.
    23,040 USD22SEC
    6,000 shares@ US$3.840.9% of flowClass A Common StockSEC:0001232583-17-000004:0
  • ▼
    CEO, Valence HealthExecutivesEvolent Health, Inc.
    122,483 USD40SEC
    5,300 shares@ US$23.114.8% of flowClass A Common StockSEC:0001232583-17-000004:1
  • ▼
    CEO, Valence HealthExecutivesEvolent Health, Inc.
    16,387 USD40SEC
    700 shares@ US$23.410.6% of flowClass A Common StockSEC:0001232583-17-000004:2
  • ▼
    CEO, Valence HealthExecutivesEvolent Health, Inc.
    19,958 USD37SEC
    988 shares@ US$20.200.8% of flowClass A Common StockSEC:0001232583-17-000003:0
  • ◇
    CEO, Valence HealthExecutivesEvolent Health, Inc.
    23,040 USD22SEC
    6,000 shares@ US$3.840.9% of flowClass A Common StockSEC:0001232583-17-000002:0
  • ▼
    CEO, Valence HealthExecutivesEvolent Health, Inc.
    120,660 USD37SEC
    6,000 shares@ US$20.114.8% of flowClass A Common StockSEC:0001232583-17-000002:1
  • ◇
    CEO, Valence HealthExecutivesEvolent Health, Inc.
    46,080 USD22SEC
    12,000 shares@ US$3.841.8% of flowClass A Common StockSEC:0001232583-17-000001:0
  • ▼
    CEO, Valence HealthExecutivesEvolent Health, Inc.
    120,720 USD37SEC
    6,000 shares@ US$20.124.8% of flowClass A Common StockSEC:0001232583-17-000001:1
  • ▼
    CEO, Valence HealthExecutivesEvolent Health, Inc.
    120,780 USD37SEC
    6,000 shares@ US$20.134.8% of flowClass A Common StockSEC:0001232583-17-000001:2
  • ▼
    Chief Development OfficerExecutivesEvolent Health, Inc.
    985,670 USD33SEC
    45,760 shares@ US$21.5437.0% of flowClass A Common StockSEC:0000950157-16-002181:0
  • ◆
    Chief Development OfficerExecutivesEvolent Health, Inc.
    0SEC
    6,329 shares0Class A Common StockSEC:0001140361-16-056452:0

22 of 22 declarations